Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
Displaying 3 of 2697 articles.

Search committee formed to identify Marc Tessier-Lavigne’s successor

When President Marc Tessier-Lavigne announced earlier this month that he will be leaving the university in September to become the next president of Stanford University, the news was met with praise for his many accomplishments by the campus community, the Rockefeller Board of Trustees, and its chai...

Timothy O’Connor appointed executive vice president

by Eva Kiesler, managing editor The Rockefeller Board of Trustees has approved the appointment of Timothy O’Connor as executive vice president of the university, effective February 17. In his former role as chief of staff and vice president, Dr. O’Connor provided high-level support to presi...

In the News - PBS Frontline - Kreek

The Options and Obstacles to Treating Heroin Addiction   "'Methadone became stigmatized almost immediately,' says Dr. Mary Jeanne Kreek of Rockefeller University. Kreek was part of the team that originally studied methadone as a potential treatment for opioid addiction in the 1960s. She notes tha...

Recent Awards and Honors

Katya Vinogradova

Ekaterina V. Vinogradova receives Damon Runyon-Rachleff Innovation Award

January 11, 2022

Vinogradova receives the award for her work exploring how lung tumors suppress immune responses.

Charles M. Rice

Charles M. Rice is elected to the National Academy of Inventors

December 7, 2021

Rice receives the honor for pioneering novel methods for growing and studying hepatitis C virus.

More awards and honors

Rockefeller in the News

The New York Times

“People that are vaccinated really are doing very well in terms of hospitalization,” said Michel Nussenzweig, an immunologist at Rockefeller University in New York.

STAT News

“I was much more confident a couple of weeks ago that the antibodies would have the edge in being able to outstrip the evolutionary capacity of SARS-CoV-2. But I don’t think that’s completely clear now,” Paul Bieniasz said.

The New York Times

“What molnupiravir does is it disguises itself,” Elizabeth Campbell, an expert in structural biology at the Rockefeller University who studies coronavirus antivirals, said in an interview. “It can propagate errors that are going to be sprinkled all over the genome.”

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes a look at how the brain’s internal states drive its remarkable ability to reach different conclusion based on the same information. Also: The latest from Rockefeller’s COVID labs, and much more.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.